View the Zacks #1 Rank List
View All Zacks #1 Ranked StocksREGN 632.90 +12.76(2.06%)
Will REGN be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for REGN based on the 1-3 month trading system that more than doubles the S&P 500.
-
MU
Micron Technology
-
#1
-
AAPL
Apple
-
#2
-
NVDA
NVIDIA
-
#3
-
PLTR
Palantir Technologies
-
#4
-
SPCX
Space Exploration Technologies Corp.
-
#5
-
SNDK
Sandisk Corporation
-
#6
-
AVGO
Broadcom
-
#7
Zacks News for REGN
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now
BAYRY Stock Surges 17% After Supreme Court Roundup Ruling
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Regeneron's Applications for gMG Drug Accepted by FDA and EMA
ABBV Jumps on Deepening Immunology Portfolio With $10.9B APGE Buyout
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
Other News for REGN
Regeneron Expands Metabolic Footprint With New Phase 2a Fatty Liver Study
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade)
REGN rises 2.06% on June 26, leaving the technical picture intact
REGN forms Shooting Star Candlestick on June 25
Regeneron’s New First-in-Human Eczema Drug REGN20423: Early Trial Progress and Investor Takeaways